EBR Systems (ASX:EBR) submitted its application to the US Centers for Medicare & Medicaid Services for the transitional pass-through reimbursement scheme for its WiSE cardiac resynchronization therapy system, according to a Monday filing with the Australian bourse.
The reimbursement program aims to facilitate hospital adoption of medical technologies that demonstrate substantial clinical improvement for patients but are not yet fully incorporated into standard Medicare payment rates, the filing said.
The program is expected to be effective from Oct. 1, according to the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.